A detailed history of Israel Englander (Millennium Management LLC) transactions in Celcuity Inc. stock. As of the latest transaction made, Millennium Management LLC holds 20,682 shares of CELC stock, worth $307,127. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,682
Previous 89,275 76.83%
Holding current value
$307,127
Previous $1.93 Million 82.47%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$14.1 - $20.78 $967,161 - $1.43 Million
-68,593 Reduced 76.83%
20,682 $338,000
Q1 2024

May 15, 2024

BUY
$13.74 - $21.6 $1.23 Million - $1.93 Million
89,275 New
89,275 $1.93 Million
Q2 2023

Aug 14, 2023

SELL
$9.39 - $12.18 $2.8 Million - $3.64 Million
-298,688 Reduced 76.16%
93,479 $1.03 Million
Q1 2023

May 15, 2023

SELL
$9.4 - $12.82 $454,179 - $619,423
-48,317 Reduced 10.97%
392,167 $4.02 Million
Q4 2022

Feb 14, 2023

SELL
$7.55 - $14.01 $97,183 - $180,336
-12,872 Reduced 2.84%
440,484 $6.17 Million
Q3 2022

Nov 14, 2022

SELL
$8.0 - $10.64 $447,128 - $594,680
-55,891 Reduced 10.98%
453,356 $4.55 Million
Q2 2022

Aug 15, 2022

BUY
$5.35 - $10.11 $912,800 - $1.72 Million
170,617 Added 50.38%
509,247 $4.63 Million
Q1 2022

May 16, 2022

BUY
$7.93 - $13.33 $2.3 Million - $3.86 Million
289,788 Added 593.32%
338,630 $3.17 Million
Q4 2021

Feb 14, 2022

SELL
$11.96 - $19.35 $750,908 - $1.21 Million
-62,785 Reduced 56.25%
48,842 $644,000
Q3 2021

Nov 15, 2021

BUY
$17.35 - $24.87 $790,813 - $1.13 Million
45,580 Added 69.01%
111,627 $2.01 Million
Q2 2021

Aug 16, 2021

BUY
$14.25 - $30.93 $941,169 - $2.04 Million
66,047 New
66,047 $1.59 Million
Q1 2018

May 15, 2018

SELL
$13.55 - $21.3 $165,310 - $259,860
-12,200 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$12.12 - $21.65 $147,864 - $264,130
12,200
12,200 $231,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $222M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.